High Throughput Sequencing for Clinical Tuberculosis: An Overview
- PMID: 36422596
- PMCID: PMC9695813
- DOI: 10.3390/pathogens11111343
High Throughput Sequencing for Clinical Tuberculosis: An Overview
Abstract
High throughput sequencing (HTS) can identify the presence of Mycobacterium tuberculosis DNA in a clinical sample while also providing information on drug susceptibility. Multiple studies have provided a context for exploring the clinical application of HTS for TB diagnosis. The workflow challenges, strengths and limitations of the various sequencing platforms, and tools used for analysis are presented to provide a framework for further innovations in the field.
Keywords: Mycobacterium tuberculosis; high throughput sequencing; next generation sequencing; sequencing; tuberculosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- WHO . The END TB Strategy. World Health Organization; Geneva, Switzerland: 2014.
-
- Walker T.M., Ip C.L., Harrell R.H., Evans J.T., Kapatai G., Dedicoat M.J., Eyre D.W., Wilson D.J., Hawkey P.M., Crook D.W., et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: A retrospective observational study. Lancet Infect. Dis. 2013;13:137–146. doi: 10.1016/S1473-3099(12)70277-3. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
